PuriCore receives FDA approval for disinfectant system

Published: 2-May-2007


PuriCore, the life sciences company focused on the development and commercialisation of its novel, safe antimicrobial technology, has received 510(k) clearance from the US Food and Drug Administration (FDA).

The clearance allows the firm to market its proprietary Sterilox Endoscopy Disinfectant System as a medical device in the US. The system produces an effective and safe high-level disinfectant solution that is indicated for use in reprocessing and disinfecting heat-sensitive medical instruments, including endoscopes, between patient procedures.

The unit produces hypochlorous acid, the natural antimicrobial produced by the human body to fight pathogens, from the electrolysis of a saline solution. Sterilox Solutions are completely non-toxic and are of no risk to patients, healthcare professionals, or the environment.

Greg Bosch, PuriCore ceo, said” "We are now developing our commercialisation plan and, upon the completion of post-clearance testing, we anticipate installing our first US beta sites for Sterilox endoscopy systems by the end of the year.”

You may also like